These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22416677)

  • 41. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
    Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
    Backer CL; Kelle AM; Stewart RD; Suresh SC; Ali FN; Cohn RA; Seshadri R; Mavroudis C
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of tranexamic acid compared with aprotinin in thoracic aortic surgery with deep hypothermic circulatory arrest.
    Nicolau-Raducu R; Subramaniam K; Marquez J; Wells C; Hilmi I; Sullivan E
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):73-9. PubMed ID: 19717314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery.
    Oliver WC; Fass DN; Nuttall GA; Dearani JA; Schrader LM; Schroeder DR; Ereth MH; Puga FJ
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1670-7. PubMed ID: 15173722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery.
    Guzzetta NA
    Paediatr Anaesth; 2011 May; 21(5):504-11. PubMed ID: 21114707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery.
    Golab HD; Takkenberg JJ; van Gerner-Weelink GL; Wijers MJ; Scohy TV; de Jong PL; Bogers AJ
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):335-9. PubMed ID: 17669859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations.
    Székely A; Cserép Z; Sápi E; Breuer T; Nagy CA; Vargha P; Hartyánszky I; Szatmári A; Treszl A
    Ann Thorac Surg; 2009 Jan; 87(1):187-97. PubMed ID: 19101294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis.
    Sander M; Spies CD; Martiny V; Rosenthal C; Wernecke KD; von Heymann C
    Crit Care; 2010; 14(4):R148. PubMed ID: 20682059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
    Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
    Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benefits and risks of aprotinin use during cardiac surgery.
    Kristeller JL; Roslund BP; Stahl RF
    Pharmacotherapy; 2008 Jan; 28(1):112-24. PubMed ID: 18154481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R;
    N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of high doses of aprotinin in cardiac surgery].
    Carrera A; Martínez MV; García-Guiral M; Herrero E; Peral A; Planas A
    Rev Esp Anestesiol Reanim; 1994; 41(1):13-9. PubMed ID: 7517058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss.
    Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):705-11. PubMed ID: 7682266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aprotinin during coronary-artery bypass grafting and risk of death.
    Schneeweiss S; Seeger JD; Landon J; Walker AM
    N Engl J Med; 2008 Feb; 358(8):771-83. PubMed ID: 18287600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimizing intraoperative hemodilution by use of a very low priming volume cardiopulmonary bypass in neonates with transposition of the great arteries.
    Redlin M; Huebler M; Boettcher W; Kukucka M; Schoenfeld H; Hetzer R; Habazettl H
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):875-81. PubMed ID: 21570096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
    Martin K; Breuer T; Gertler R; Hapfelmeier A; Schreiber C; Lange R; Hess J; Wiesner G
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):892-7. PubMed ID: 21115357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.